Gliclazide Mr 30mg, 60mg Modified-release tablets.
PDF Leaflet Revision Date: Not applicable
Clinical Summary
Quick overview from the medicine insert
Indication
For Type 2 diabetes management when diet and exercise are insufficient.
Dosage (summary)
Initial: 30 mg once daily with breakfast; max: 120 mg/day.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding due to potential risks.
Key Drug Interactions
- Miconazole
- Alcohol
- Other antidiabetic medicines
Contraindications
- Hypersensitivity to gliclazide
- Type 1 diabetes
- Severe renal or hepatic insufficiency
- Children
Common side effects
- Hypoglycaemia
- Nausea
- Abdominal pain
- Rash
Counselling Points
- Take with breakfast
- Monitor blood glucose regularly
- Avoid alcohol
Serious warnings
- Risk of hypoglycaemia
- Careful monitoring in renal impairment
Important Disclaimer
The Gliclazide Mr 30mg, 60mg Modified-release tablets. professional information leaflet below is the property of Zydus Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
